12-4273992-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001759.4(CCND2):​c.-49T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.995 in 1,571,080 control chromosomes in the GnomAD database, including 778,531 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 72379 hom., cov: 31)
Exomes 𝑓: 1.0 ( 706152 hom. )

Consequence

CCND2
NM_001759.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0480
Variant links:
Genes affected
CCND2 (HGNC:1583): (cyclin D2) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014]
CCND2-AS1 (HGNC:49398): (CCND2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 12-4273992-T-C is Benign according to our data. Variant chr12-4273992-T-C is described in ClinVar as [Benign]. Clinvar id is 1192627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CCND2NM_001759.4 linkuse as main transcriptc.-49T>C 5_prime_UTR_variant 1/5 ENST00000261254.8
CCND2-AS1NR_125790.1 linkuse as main transcriptn.126+2067A>G intron_variant, non_coding_transcript_variant
CCND2-AS1NR_149145.1 linkuse as main transcriptn.182+1304A>G intron_variant, non_coding_transcript_variant
CCND2-AS1NR_149146.1 linkuse as main transcriptn.182+1304A>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CCND2ENST00000261254.8 linkuse as main transcriptc.-49T>C 5_prime_UTR_variant 1/51 NM_001759.4 P1P30279-1
CCND2-AS1ENST00000663068.1 linkuse as main transcriptn.194+2067A>G intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.974
AC:
148201
AN:
152100
Hom.:
72318
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.911
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.990
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.994
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.980
GnomAD3 exomes
AF:
0.994
AC:
200560
AN:
201822
Hom.:
99691
AF XY:
0.995
AC XY:
109764
AN XY:
110286
show subpopulations
Gnomad AFR exome
AF:
0.907
Gnomad AMR exome
AF:
0.995
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad SAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.998
GnomAD4 exome
AF:
0.998
AC:
1415437
AN:
1418862
Hom.:
706152
Cov.:
26
AF XY:
0.998
AC XY:
701687
AN XY:
703146
show subpopulations
Gnomad4 AFR exome
AF:
0.912
Gnomad4 AMR exome
AF:
0.995
Gnomad4 ASJ exome
AF:
1.00
Gnomad4 EAS exome
AF:
1.00
Gnomad4 SAS exome
AF:
1.00
Gnomad4 FIN exome
AF:
1.00
Gnomad4 NFE exome
AF:
1.00
Gnomad4 OTH exome
AF:
0.995
GnomAD4 genome
AF:
0.974
AC:
148322
AN:
152218
Hom.:
72379
Cov.:
31
AF XY:
0.975
AC XY:
72582
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.911
Gnomad4 AMR
AF:
0.990
Gnomad4 ASJ
AF:
1.00
Gnomad4 EAS
AF:
1.00
Gnomad4 SAS
AF:
1.00
Gnomad4 FIN
AF:
1.00
Gnomad4 NFE
AF:
1.00
Gnomad4 OTH
AF:
0.981
Alfa
AF:
0.994
Hom.:
26620
Bravo
AF:
0.971
Asia WGS
AF:
0.997
AC:
3467
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.3
DANN
Benign
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3217786; hg19: chr12-4383158; COSMIC: COSV54225474; COSMIC: COSV54225474; API